Advances in the field of infectious disease (ID) testing have provided the core laboratory with an extraordinary opportunity to take a more prominent role in the care of patients with infectious and sexually transmitted diseases. In conventional testing, the laboratory’s contribution to patient care ended with identification of the organism; it was then up to physicians to prescribe treatment and monitor the patient’s progress.

Now, with a host of new platforms and test technologies, laboratorians can confidently guide physician treatment of patients, help ensure that patients comply with their drug therapy regimens, provide information to help monitor treatment and optimize the use of health care resources.

Attend this conference and learn from top ID experts how to:

• manage threats posed by MRSA and C. difficile
• decide when to bring on new ID tests and testing platforms
• optimize automated antimicrobial susceptibility testing
• evaluate the strengths and weaknesses of culture vs. molecular diagnostics
• institute effective test algorithms for screening/diagnosis of HIV and hepatitis

Don’t miss this opportunity to learn about the latest developments in ID testing, including the most successful management strategies.

For more information or to register, visit http://direct.aacc.org/ProductCatalog/Product.aspx?ID=5209.